Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT06925243 · RECRUITING

Trial details

NCT number: NCT06925243
Sponsor: Zuoyi Jiao
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Neoadjuvant Therapy Adjuvant Chemotherapy pCR Rate MPR ORR,OS,PFS

Start date: 2025-04-15
Primary completion: 2027-12-31
Enrollment: 682

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.